Topics:

John W. Goethe, MD

John W. Goethe, MD

Posts by Author

Although most studies have focused on the risk of metabolic syndrome for patients with schizophrenia exposed to atypical antipsychotics, other psychiatric patients appear to be at risk for metabolic disturbances as well.7-9 Major depressive disorder (MDD) may be of particular interest because it is much more common than schizophrenia and is treated with a broad range of psychotropics.

By clicking Accept, you agree to become a member of the UBM Medica Community.